Sandra S Chaves1, Alejandro Perez, Monica M Farley, Lisa Miller, William Schaffner, Mary L Lindegren, Ruta Sharangpani, James Meek, Kimberley Yousey-Hindes, Ann Thomas, Rachelle Boulton, Joan Baumbach, Emily B Hancock, Ananda S Bandyopadhyay, Ruth Lynfield, Craig Morin, Shelley M Zansky, Arthur Reingold, Nancy M Bennett, Patricia Ryan, Brian Fowler, Alicia Fry, Lyn Finelli. 1. From the *Centers for Disease Control and Prevention; †Emory University School of Medicine; ‡Atlanta Veterans Administration Medical Center, Atlanta, GA; §Colorado Department of Public Health and Environment, Denver, CO; ¶Department of Preventive Medicine, Vanderbilt University School of Medicine, Nashville, TN; ‖Michigan Department of Community Health, Lansing, MI; **Connecticut Emerging Infections Program, School of Public Health, New Haven, CT; ††Oregon Public Health Division, Portland, OR; ‡‡Utah Department of Health, Salt Lake City, UT; §§New Mexico Department of Health, Santa Fe, NM; ¶¶Rhode Island Department of Health, Providence, RI; ‖‖Minnesota Department of Health, St. Paul, MN; ***Emerging Infections Program, New York State Department of Health, Albany, NY; †††California Emerging Infections Program, Oakland, CA; ‡‡‡Department of Medicine, University of Rochester School of Medicine and Dentistry; §§§Monroe County, Department of Public Health, Rochester, NY; ¶¶¶Maryland Department of Health and Mental Hygiene, Baltimore, MD; and ‖‖‖Ohio Department of Health, Columbus, OH.
Abstract
BACKGROUND: Little information is available describing the epidemiology and clinical characteristics of those <12 months hospitalized with influenza, particularly at a population level. METHODS: We used population-based, laboratory-confirmed influenza hospitalization surveillance data from 2003 to 2012 seasons to describe the impact of influenza by age category (<3, 3 to <6 and 6 to <12 months). Logistic regression was used to explore risk factors for intensive care unit (ICU) admission. Adjusted age-specific, influenza-associated hospitalization rates were calculated and applied to the number of US infants to estimate national numbers of hospitalizations. RESULTS: Influenza was associated with an annual average of 6514 infant hospitalizations (range 1842-12,502). Hospitalization rates among infants <3 months were substantially higher than the rate in older infants. Most hospitalizations occurred in otherwise healthy infants (75%) among whom up to 10% were admitted to the ICU and up to 4% had respiratory failure. These proportions were 2-3 times higher in infants with high risk conditions. Infants <6 months were 40% more likely to be admitted to the ICU than older infants. Lung disease (adjusted odds ratio 1.80; 95% confidence interval 1.22-2.67), cardiovascular disease (adjusted odds ratio: 4.16; 95% confidence interval: 2.65-6.53), and neuromuscular disorder (adjusted odds ratio: 2.99; 95% confidence interval: 1.87-4.78) were risk factors for ICU admission among all infants. CONCLUSIONS: The impact of influenza on infants, particularly those very young or with high risk conditions, underscores the importance of influenza vaccination, especially among pregnant women and those in contact with young infants not eligible for vaccination.
BACKGROUND: Little information is available describing the epidemiology and clinical characteristics of those <12 months hospitalized with influenza, particularly at a population level. METHODS: We used population-based, laboratory-confirmed influenza hospitalization surveillance data from 2003 to 2012 seasons to describe the impact of influenza by age category (<3, 3 to <6 and 6 to <12 months). Logistic regression was used to explore risk factors for intensive care unit (ICU) admission. Adjusted age-specific, influenza-associated hospitalization rates were calculated and applied to the number of US infants to estimate national numbers of hospitalizations. RESULTS: Influenza was associated with an annual average of 6514 infant hospitalizations (range 1842-12,502). Hospitalization rates among infants <3 months were substantially higher than the rate in older infants. Most hospitalizations occurred in otherwise healthy infants (75%) among whom up to 10% were admitted to the ICU and up to 4% had respiratory failure. These proportions were 2-3 times higher in infants with high risk conditions. Infants <6 months were 40% more likely to be admitted to the ICU than older infants. Lung disease (adjusted odds ratio 1.80; 95% confidence interval 1.22-2.67), cardiovascular disease (adjusted odds ratio: 4.16; 95% confidence interval: 2.65-6.53), and neuromuscular disorder (adjusted odds ratio: 2.99; 95% confidence interval: 1.87-4.78) were risk factors for ICU admission among all infants. CONCLUSIONS: The impact of influenza on infants, particularly those very young or with high risk conditions, underscores the importance of influenza vaccination, especially among pregnant women and those in contact with young infants not eligible for vaccination.
Authors: Ikwo K Oboho; Anna Bramley; Lyn Finelli; Alicia Fry; Krow Ampofo; Sandra R Arnold; Wesley H Self; Derek J Williams; D Mark Courtney; Yuwei Zhu; Evan J Anderson; Carlos G Grijalva; Jonathan A McCullers; Richard G Wunderink; Andrew T Pavia; Kathryn M Edwards; Seema Jain Journal: Open Forum Infect Dis Date: 2016-12-27 Impact factor: 3.835
Authors: Rebecca J Hart; Michelle D Stevenson; Michael J Smith; A Scott LaJoie; Keith Cross Journal: JAMA Pediatr Date: 2018-01-02 Impact factor: 16.193
Authors: Mark G Thompson; Min Z Levine; Silvia Bino; Danielle R Hunt; Tareq M Al-Sanouri; Eric A F Simões; Rachael M Porter; Holly M Biggs; Lionel Gresh; Artan Simaku; Illham Abu Khader; Veronica L Tallo; Jennifer K Meece; Meredith McMorrow; Edelwisa S Mercado; Sneha Joshi; Nicholas P DeGroote; Iris Hatibi; Felix Sanchez; Marilla G Lucero; Samir Faouri; Stacie N Jefferson; Numila Maliqari; Angel Balmaseda; Diozele Sanvictores; Crystal Holiday; Cristina Sciuto; Zachary Owens; Eduardo Azziz-Baumgartner; Aubree Gordon Journal: Lancet Child Adolesc Health Date: 2019-09-03
Authors: Jesús San Román Montero; Ruth Gil-Prieto; Rubén Jiménez Martín; Raúl Ortiz de Lejarazu; Carmen Gallardo-Pino; Angel Gil de Miguel Journal: Hum Vaccin Immunother Date: 2020-12-22 Impact factor: 3.452
Authors: Constance E Ogokeh; Angela P Campbell; Leora R Feldstein; Geoffrey A Weinberg; Mary A Staat; Monica M McNeal; Rangaraj Selvarangan; Natasha B Halasa; Janet A Englund; Julie A Boom; Parvin H Azimi; Peter G Szilagyi; Christopher J Harrison; John V Williams; Eileen J Klein; Laura S Stewart; Leila C Sahni; Monica N Singer; Joana Y Lively; Daniel C Payne; Manish Patel Journal: J Pediatric Infect Dis Soc Date: 2021-04-30 Impact factor: 5.235
Authors: Meredith L McMorrow; Gideon O Emukule; Henry N Njuguna; Godfrey Bigogo; Joel M Montgomery; Bryan Nyawanda; Allan Audi; Robert F Breiman; Mark A Katz; Leonard Cosmas; Lilian W Waiboci; Jazmin Duque; Marc-Alain Widdowson; Joshua A Mott Journal: PLoS One Date: 2015-09-17 Impact factor: 3.240
Authors: Rebecca C Brady; Lisa A Jackson; Sharon E Frey; Andi L Shane; Emmanuel B Walter; Geeta K Swamy; Elizabeth P Schlaudecker; Elena Szefer; Mark Wolff; Monica Malone McNeal; David I Bernstein; Mark C Steinhoff Journal: Vaccine Date: 2018-06-28 Impact factor: 3.641